When teaching a patient who is beginning antilipemic therapy about possible drug-food interactions, the nurse will discuss which food?

Choice A reason: Dairy products do not significantly interact with antilipemic drugs like statins, which are commonly used. They may affect dietary cholesterol but not drug metabolism. Grapefruit juice is a key interaction, making dairy an incorrect focus for teaching about antilipemic therapy drug-food interactions. Choice B reason: Licorice may affect blood pressure or potassium but is not a primary concern for antilipemic therapy interactions. Grapefruit juice inhibits statin metabolism, increasing drug levels and side effect risks, making licorice an incorrect choice for this teaching focus compared to grapefruit juice. Choice C reason: Oatmeal, rich in fiber, benefits cholesterol levels but does not interact adversely with antilipemic drugs like statins. Grapefruit juice is the critical interaction due to enzyme inhibition, making oatmeal an incorrect choice, as it lacks significant drug-food interaction with antilipemic therapy. Choice D reason: Grapefruit juice inhibits the CYP3A4 enzyme, affecting statin metabolism, increasing drug levels, and risking toxicity like myopathy. This is a critical drug-food interaction for antilipemic therapy, making it the correct food to discuss in teaching to ensure safe medication use and avoid adverse effects.